Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Cash & Equivalents (2016 - 2026)

Option Care Health (OPCH) has disclosed Cash & Equivalents for 16 consecutive years, with $177.3 million as the latest value for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 3.47% year-over-year to $177.3 million; the TTM value through Mar 2026 reached $177.3 million, up 3.47%, while the annual FY2025 figure was $232.6 million, 43.62% down from the prior year.
  • Cash & Equivalents hit $177.3 million in Q1 2026 for Option Care Health, down from $232.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $483.0 million in Q3 2024 and bottomed at $145.6 million in Q1 2022.
  • Average Cash & Equivalents over 5 years is $291.2 million, with a median of $294.2 million recorded in 2022.
  • Year-over-year, Cash & Equivalents soared 146.34% in 2022 and then tumbled 47.25% in 2025.
  • Option Care Health's Cash & Equivalents stood at $294.2 million in 2022, then grew by 16.88% to $343.8 million in 2023, then increased by 19.98% to $412.6 million in 2024, then plummeted by 43.62% to $232.6 million in 2025, then dropped by 23.77% to $177.3 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $177.3 million, $232.6 million, and $309.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.